BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26453487)

  • 1. A Novel In Vivo Protocol for Molecular Study of Radiation-Induced Fibrosis in Head and Neck Cancer Patients.
    Krisciunas GP; Platt M; Trojanowska M; Grillone GA; Haines PC; Langmore SE
    Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):228-34. PubMed ID: 26453487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular electrical stimulation improves radiation-induced fibrosis through Tgf-Β1/MyoD homeostasis in head and neck cancer.
    Peng G; Masood K; Gantz O; Sinha U
    J Surg Oncol; 2016 Jul; 114(1):27-31. PubMed ID: 27144672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Ultrasonic Nakagami Imaging of Neck Fibrosis After Head and Neck Radiation Therapy.
    Yang X; Yoshida E; Cassidy RJ; Beitler JJ; Yu DS; Curran WJ; Liu T
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):407-14. PubMed ID: 25817529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An expression analysis of markers of radiation-induced skin fibrosis and angiogenesis in wound healing disorders of the head and neck.
    Koerdt S; Rohleder NH; Rommel N; Nobis C; Stoeckelhuber M; Pigorsch S; Duma MN; Wolff KD; Kesting MR
    Radiat Oncol; 2015 Sep; 10():202. PubMed ID: 26390925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
    Lu H; Yao M; Tan H
    Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
    Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
    Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol.
    Chen AM; Wang PC; Daly ME; Cui J; Hall WH; Vijayakumar S; Phillips TL; Farwell DG; Purdy JA
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):771-7. PubMed ID: 24606846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer.
    Saunders MI; Rojas AM; Parmar MK; Dische S;
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):3-8. PubMed ID: 20394851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying fibrosis in head and neck cancer treatment: An overview.
    Moloney EC; Brunner M; Alexander AJ; Clark J
    Head Neck; 2015 Aug; 37(8):1225-31. PubMed ID: 24797251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
    Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
    Milano MT; Vokes EE; Kao J; Jackson W; List MA; Stenson KM; Witt ME; Dekker A; MacCracken E; Garofalo MC; Chmura SJ; Weichselbaum RR; Haraf DJ
    Int J Oncol; 2006 May; 28(5):1141-51. PubMed ID: 16596230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of head-and-neck radiation therapy in human immunodeficiency virus-positive patients.
    Sanfilippo NJ; Mitchell J; Grew D; DeLacure M
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1375-9. PubMed ID: 20097488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Tomotherapy to spare the cochlea from excessive radiation in head and neck cancer.
    Nguyen NP; Smith-Raymond L; Vinh-Hung V; Sloan D; Davis R; Vos P; Abraham D; Stevie M; Krafft SP; Ly BH; Ries T; Karlsson U; Ceizyk M
    Oral Oncol; 2011 May; 47(5):414-9. PubMed ID: 21474364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
    Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
    Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
    Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation effects on the intima-media thickness of the common carotid artery in post-radiotherapy patients with head and neck malignancy.
    Shariat M; Alias NA; Biswal BM
    Postgrad Med J; 2008 Nov; 84(997):609-12. PubMed ID: 19103820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.